Kaveri S Bio Proteins Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.38 Cr
as on 24-10-2024
- Company Age 34 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.30 Cr
as on 24-10-2024
- Satisfied Charges ₹ 15.02 Cr
as on 24-10-2024
- Revenue 64.57%
(FY 2023)
- Profit 81.01%
(FY 2023)
- Ebitda 106.63%
(FY 2023)
- Net Worth 10.57%
(FY 2023)
- Total Assets 42.56%
(FY 2023)
About Kaveri S Bio Proteins
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.38 Cr.
The company currently has active open charges totaling ₹4.30 Cr. The company has closed loans amounting to ₹15.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkatachalam Suseela and Venkatachalam Senthil serve as directors at the Company.
- CIN/LLPIN
U15139TZ1990PTC002970
- Company No.
002970
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Namakkal, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kaveri S Bio Proteins Private Limited offer?
Kaveri S Bio Proteins Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Kaveri S Bio Proteins?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatachalam Suseela  | Director | 06-Dec-1990 | Current |
| Venkatachalam Senthil | Director | 08-Jul-2016 | Current |
Financial Performance of Kaveri S Bio Proteins.
Kaveri S Bio Proteins Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 64.57% increase. The company also saw a substantial improvement in profitability, with a 81.01% increase in profit. The company's net worth Soared by an impressive increase of 10.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaveri S Bio Proteins?
In 2023, Kaveri S Bio Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Jul 2011 | ₹4.30 Cr | Open |
Hdfc Bank Limited Creation Date: 20 May 2013 | ₹4.10 Cr | Satisfied |
Kotak Mahindra Bank Limited Creation Date: 03 Nov 2011 | ₹8.00 M | Satisfied |
How Many Employees Work at Kaveri S Bio Proteins?
Unlock and access historical data on people associated with Kaveri S Bio Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaveri S Bio Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaveri S Bio Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
